TFF Pharmaceuticals
Executives
View the org chart displaying its 11 main executives
Most searched biographies at TFF Pharmaceuticals
- Harlan Weisman, Vice Chairman of the Board and Chief Executive Off...
- Stephen Rocamboli, Director
- Robert Mills, Director
Popular executive movements at TFF Pharmaceuticals
- Thomas King has joined the company as Director (posted on December 14 2023).
- Catherine Lee has joined the company as Director (posted on December 1 2023).
Create your alert
to follow the executive moves at TFF Pharmaceuticals.
Pharmaceuticals
TFF Pharmaceuticals has 1,862 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I
- TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Update on Clinical Programs | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | TFF Pharmaceuticals
- TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024 | TFF Pharmaceuticals
- TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting | TFF Pharmaceuticals
- View more press releases Close
Social media about TFF Pharmaceuticals
- TFF Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- TFF Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Harlan Weisman 
Call TFF Pharmaceuticals at +1 737...
